Zynerba Pharmaceuticals, Inc. Gains 35.09%

Thu, Jun 09, 2022 at 05:30 PM
Zynerba Pharmaceuticals, Inc. Gains 35.09%

Zynerba Pharmaceuticals, Inc. (ZYNE:NASDAQ) jumped higher at $1.29, representing a gain of 35.1%. On Wed, Jun 08, 2022, ZYNE:NASDAQ touched a New 2-Week Intraday High of $1.02. The stock appeared on our News Catalysts scanner on Wed, Jun 01, 2022 at 07:16 AM in the 'BIOTECH' category. From Wed, May 25, 2022, the stock recorded 55.56% Up Days and 40.00% Green Days

The share price of the company has been moving sideways in recent weeks.

About Zynerba Pharmaceuticals, Inc. (ZYNE:NASDAQ)

Zynerba Pharmaceuticals Inc together with its subsidiary is a pharmaceutical company which is focused on developing and commercializing proprietary next generation synthetic cannabinoid therapeutics formulated for transdermal delivery.

Get 50% Off Premium Subscription
$19.99 USD
Limited-Time Discount
$9.99 USD
Signup 7 Days Trial. No Credit Card Required!
Ever wanted to explore stocks that have recently spiked... stocks moving sideways... gaps... or other trends? You're in the right place! Check StockTreats features.